July 7, 2020 -- Li-Cor Biosciences offers research solutions for therapeutics development and western blotting. Now, the company is offering researchers a special Odyssey Clx Viral Solution package at a reduced price to support COVID-19 research.
Traditionally, researchers use plaque assays to determine infectivity of SARS-CoV-2 and other viruses. Alternatively, Li-Cor's near-infrared western blot and in-cell western assays offer a rapid and reliable method to study viruses like SARS-CoV-2.
The package includes the Odyssey Imager, startup reagents, basic and advanced virtual training from Li-Cor scientists, and Empiria Studio statistical analysis software.